project id: TCGA-THCA; case submitter id: TCGA-ET-A3BO; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.0; rna integrity number: 7.6; age at index: 44; days to birth: -16110; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1966; age at diagnosis: 16110; ajcc pathologic m: MX; ajcc pathologic n: N1a; ajcc pathologic stage: Stage I; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1533.0; icd 10 code: C73; last known disease status: not reported; morphology: 8344/3; primary diagnosis: Papillary carcinoma, columnar cell; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: Not Reported; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 283; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-ET-A3BO-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;